About Mininavident
Mininavident is a company based in Basel (Switzerland) founded in 2013 by Frank Berlinghoff and Hans-Florian Zeilhofer was acquired by Straumann Group in August 2024. Mininavident has raised $1.42 million across 2 funding rounds from investors including Straumann Group, Nobel Biocare and W&H. Mininavident operates in a competitive market with competitors including Neocis, ClaroNav, Onpharma, SensableDental and X-Nav Technologies, among others.
- Headquarter Basel, Switzerland
- Founders Frank Berlinghoff, Hans-Florian Zeilhofer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.42 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Straumann Group
& 3 more
-
Employee Count
Not available
-
Acquired by
Straumann Group
(Aug 30, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Mininavident
Unlock access to complete
Unlock access to complete
Funding Insights of Mininavident
Mininavident has successfully raised a total of $1.42M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Mininavident
Mininavident has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Straumann Group, Nobel Biocare and W&H.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Dental implants and regenerative dentistry products are developed.
|
Locked | Locked | Locked | |
|
W&H is recognized for manufacturing high-quality dental equipment.
|
Locked | Locked | Locked | |
|
Offers banking services including accounts, loans, investments, and advisory for customers.
|
Locked | Locked | Locked |
Investor details for Mininavident
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mininavident
Investment portfolio details for Mininavident
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Mininavident
Detailed financials for Mininavident
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mininavident Comparisons
Peer comparison for Mininavident
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mininavident
Mininavident operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neocis, ClaroNav, Onpharma, SensableDental and X-Nav Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Robotic guidance systems for dental implantation surgeries are provided.
|
|
| Locked | Locked | Locked |
Medical 3D visualization and surgical navigation solutions are developed.
|
|
| Locked | Locked | Locked |
Buffer solutions and mixing pens for local anesthetics are provided.
|
|
| Locked | Locked | Locked |
3D modeling solutions, and CAD systems for dental labs
|
|
| Locked | Locked | Locked |
Surgical products for the dental market
|
Detailed competitors of Mininavident
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mininavident
Complete news archive for Mininavident
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mininavident
Mininavident was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Mininavident is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.
Werner Enz is the current CEO of Mininavident.
Mininavident is a funded company, having raised a total of $1.42M across 2 funding rounds to date.
Mininavident is a spin-off from the University Hospital Basel and the University of Applied Sciences and Arts northwestern Switzerland FHNW. They have developed a miniaturised navigation system, which is directly fitted to the surgical hand piece, and which guides the drill in real-time and in 3D to the correct implant position and angle using a ceramic dual-mode-marker and proprietary algorithms. Frank Berlinghoff is the CEO of the company.
Mininavident has 4 investors. Key investors include Straumann Group, Nobel Biocare, W&H, and Aargau Cantonal Bank.